| Company/Division name | Bora Biologics |
| Parent company | Bora Biologics |
| Type of work | Manufacturing |
| If manufacturing, is the company a contract manufacturer? | Yes |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2025 |
| Country(ies) from which reshored: | Cayman Islands |
| City reshored to: | San Diego |
| State(s) reshored to: | CA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharma |
| What domestic positive factors made reshoring more attractive? | Customization/Flexibility, Higher productivity, Lead time/Time to market, Manufacturing/engineering joint innovation (R&D), Proximity to customers/market |
